Departmemt of Gynecology Oncology, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
Am J Case Rep. 2020 Jun 1;21:e922973. doi: 10.12659/AJCR.922973.
BACKGROUND Carcinoma arising from an endometriosis-associated abdominal wall scar is a rare entity, with only a few case reports published in the literature. The management is very controversial due to on its own rarity, and there are no specific guidelines. Treatment with a multidisciplinary team is important to achieve the best outcome. CASE REPORT We report the case of a 45-year-old woman diagnosed with a growing painless lesion in the right lower quadrant. We decided to perform Tru-Cut biopsy of the abdominal wall lesion, but unfortunately the pathological report was inconclusive at that time. Due to the presence of a highly suspicious lesion, the gynecologic oncologist together with the plastic surgeon and connective tissue surgeon decided to perform a wide resection of the abdominal wall along with hysterectomy and salpingo-oophorectomy. The final pathology report demonstrated endometriosis associated with an endometrioid adenocarcinoma grade II in the abdominal wall tumor. She was restaged with new imaging exams before the definition of the best adjuvant treatment, which showed suspicious bilateral inguinal and right axillary (1.9 cm) lymph nodes, with no other sites of metastatic disease. She was treated with megestrol acetate 160 mg/daily for 8 months, with a partial response. CONCLUSIONS Carcinoma arising from an endometriosis-associated abdominal wall scar is a rare entity, and there are no no specific treatment guidelines. Such patients must be assessed by a multidisciplinary team for decision making. Options for adjuvant and palliative treatment for endometrial cancer are generally used for the treatment of this entity. The main purpose of this article is to report this rare presentation and perform a review of the literature about diagnosis, clinical presentation, treatment, and prognosis.
源自子宫内膜异位症相关腹壁瘢痕的癌是一种罕见的实体瘤,文献中仅报道了少数几例病例。由于其本身的罕见性,管理极具争议性,并且没有具体的指南。多学科团队的治疗对于获得最佳结果非常重要。
我们报告了一例 45 岁女性,诊断为右下象限生长性无痛性病变。我们决定对腹壁病变进行 Tru-Cut 活检,但不幸的是,当时的病理报告没有明确结论。由于存在高度可疑的病变,妇科肿瘤学家与整形医生和结缔组织外科医生一起决定对腹壁进行广泛切除,同时进行子宫切除术和输卵管卵巢切除术。最终的病理报告显示,腹壁肿瘤存在与子宫内膜异位症相关的子宫内膜样腺癌 II 级。在确定最佳辅助治疗之前,她接受了新的影像学检查分期,结果显示双侧腹股沟和右侧腋窝(1.9 厘米)可疑淋巴结,无其他转移部位。她接受了美替拉酮醋酸酯 160mg/天的治疗,持续 8 个月,部分缓解。
源自子宫内膜异位症相关腹壁瘢痕的癌是一种罕见的实体瘤,并且没有特定的治疗指南。此类患者必须由多学科团队进行评估以做出决策。子宫内膜癌的辅助和姑息治疗选择通常用于治疗这种实体瘤。本文的主要目的是报告这种罕见的表现,并对诊断、临床表现、治疗和预后进行文献复习。